SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
FDA
Amgen Beats Sanofi/Regeneron to European Market for Cholesterol Drug, but Race is Still on for U.S. Market
July 21, 2015
 · 
3 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Business
New Restructuring Leads to the Birth of Sanofi and Its Plan to Expand
July 16, 2015
 · 
3 min read
Sanofi Rumored to Announce Job Cuts in U.S. Before Feb. 9
Sanofi Trims Business Units From Seven to Five to Drive Growth
July 15, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
As Government Money Dwindles, Sanofi and University of Texas Team Up on Funding
July 10, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Regeneron, Sanofi’s Praluent Delivers in Late Stage Trial
July 9, 2015
 · 
4 min read
Sanofi CEO Faces Labor Headwinds As Unions Eye Bottom Line
Business
Sanofi CEO Faces Labor Headwinds As Unions Eye Bottom Line
June 26, 2015
 · 
4 min read
Business
Ousted Sanofi CEO Finds Redemption in Boston
June 23, 2015
 · 
5 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Ousted Sanofi CEO’s PureTech Nabs $171 Million in London IPO
June 19, 2015
 · 
4 min read
BIO2015 EXCLUSIVE: Biosimilars Are the
Pharm Country
BIO2015: Report Predicts GlaxoSmithKline, Merck & Co., Sanofi and Pfizer Will Be Neck and Neck in Vaccines Race by 2020
June 19, 2015
 · 
3 min read
Load More
JOBS
IN THE PRESS
Drug Development
Regeneron And Sanofi Announce New Positive Praluent (alirocumab) Phase 3 Data Presented At ESC Congress 2015
September 1, 2015
 · 
14 min read
Drug Development
Alnylam, The Medicines Company’s Long-Acting Cholesterol Drug May Threaten Amgen, Regeneron-Sanofi’s Blockbusters
August 31, 2015
 · 
9 min read
Business
Vifor Pharma Enters Two-Year Detailing Agreement With Sanofi In The United States
August 11, 2015
 · 
5 min read
Business
Sanofi Delivers Solid Sales And Business EPS Growth In Q2 2015
July 31, 2015
 · 
7 min read
Sanofi H1 2015 Results - Interview With CEO Olivier Brandicourt
July 31, 2015
 · 
1 min read
Business
Zai Lab Obtains Global Rights To Sanofi NSCLC Drug Candidate
July 31, 2015
 · 
1 min read
Business
Ligand Enters Into Commercial License And Supply Agreement With Sanofi For Captisol-Enabled SAR-125844
July 30, 2015
 · 
4 min read
Business
Lixisenatide (Lyxumia) Royalty Revenue Increased In Q2 2015 As Sanofi Confirms The Submission Of A NDA In The US
July 30, 2015
 · 
4 min read
Drug Development
Sanofi’s Lixilan Hits Phase III Goal
July 29, 2015
 · 
5 min read
FDA
FDA Approves Cholesterol Drug Praluent From Regeneron, Sanofi
July 24, 2015
 · 
16 min read
Load More